Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy, safety, and pharmacokinetics/pharmacodynamics of ocrelizumab in patients with rheumatoid arthritis; the trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED